Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Titel:
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Auteur:
Bruix, Jordi Takayama, Tadatoshi Mazzaferro, Vincenzo Chau, Gar-Yang Yang, Jiamei Kudo, Masatoshi Cai, Jianqiang Poon, Ronnie T Han, Kwang-Hyub Tak, Won Young Lee, Han Chu Song, Tianqiang Roayaie, Sasan Bolondi, Luigi Lee, Kwan Sik Makuuchi, Masatoshi Souza, Fabricio Berre, Marie-Aude Le Meinhardt, Gerold Llovet, Josep M